Electrophilic nitro-fatty acids: Anti-inflammatory mediators in the vascular compartment

Current Opinion in Pharmacology

Volumn 10, Issue 2, 2010, Pages 179-184

  Khoo, Nicholas K H ^a   Freeman, Bruce A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ELECTROPHILIC NITRO FATTY ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID DERIVATIVE; HEME OXYGENASE 1; LIPID; NITRIC OXIDE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD VESSEL INJURY; BLOOD VESSEL TONE; CELL PROLIFERATION; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION REGULATION; HEART INJURY; HUMAN; KIDNEY INJURY; MITOSIS INHIBITION; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASCULITIS;

ANIMALS; CARDIOVASCULAR DISEASES; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FATTY ACIDS; HEME OXYGENASE-1; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRO COMPOUNDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

EID: 77949760854     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.11.003     Document Type: Review

References (50)

1. Ignarro L.J., Lippton H., Edwards J.C., Baricos W.H., Hyman A.L., Kadowitz P.J., Gruetter C.A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981, 218:739-749.
2. Moncada S., Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
3. Kobs R.W., Chesler N.C. The mechanobiology of pulmonary vascular remodeling in the congenital absence of eNOS. Biomech Model Mechanobiol 2006, 5:217-225.
4. Schermuly R.T., Stasch J.P., Pullamsetti S.S., Middendorff R., Muller D., Schluter K.D., Dingendorf A., Hackemack S., Kolosionek E., Kaulen C., et al. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J 2008, 32:881-891.
5. Dumitrascu R., Weissmann N., Ghofrani H.A., Dony E., Beuerlein K., Schmidt H., Stasch J.P., Gnoth M.J., Seeger W., Grimminger F., et al. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 2006, 113:286-295.
6. Laufs U. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 2003, 58:719-731.
7. Heeba G., Moselhy M.E., Hassan M., Khalifa M., Gryglewski R., Malinski T. Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. Br J Pharmacol 2009, 156:1256-1266.
8. Rubbo H., Darley-Usmar V., Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996, 9:809-820.
9. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994, 269:26066-26075.
10. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 1996, 271:C1424-C1437.
11. Freeman B.A., Baker P.R., Schopfer F.J., Woodcock S.R., Napolitano A., d'Ischia M. Nitro-fatty acid formation and signaling. J Biol Chem 2008, 283:15515-15519.
12. Rubbo H., Radi R., Anselmi D., Kirk M., Barnes S., Butler J., Eiserich J.P., Freeman B.A. Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate. J Biol Chem 2000, 275:10812-10818.
13. Gallon A.A., Pryor W.A. The reaction of low levels of nitrogen dioxide with methyl linoleate in the presence and absence of oxygen. Lipids 1994, 29:171-176.
14. O'Donnell V.B., Taylor K.B., Parthasarathy S., Kuhn H., Koesling D., Friebe A., Bloodsworth A., Darley-Usmar V.M., Freeman B.A. 15-Lipoxygenase catalytically consumes nitric oxide and impairs activation of guanylate cyclase. J Biol Chem 1999, 274:20083-20091.
15. Ferreira A.M., Ferrari M., Trostchansky A., Batthyany C., Souza J.M., Alvarez M.N., Lopez G.V., Baker P.R., Schopfer F.J., O'Donnell V., et al. Macrophage activation induces formation of the anti-inflammatory lipid cholesteryl-nitrolinoleate. Biochem J 2009, 417:223-234.
16. O'Donnell V.B., Eiserich J.P., Chumley P.H., Jablonsky M.J., Krishna N.R., Kirk M., Barnes S., rley-Usmars V.M., Freeman B.A. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem Res Toxicol 1999, 12:83-92.
17. Rudolph V., Rudolph T.K., Schopfer F.J., Bonacci G., Woodcock S.R., Cole M.P., Baker P.R., Ramani R., Freeman B.A. Endogenous generation and protective effects of nitro-oleate in a murine model of focal cardiac ischemia and reperfusion. Cardiovasc Res 2010, 85:155-166.
18. Baker L.M., Baker P.R., Golin-Bisello F., Schopfer F.J., Fink M., Woodcock S.R., Branchaud B.P., Radi R., Freeman B.A. Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a Michael addition reaction. J Biol Chem 2007, 282:31085-31093.
19. Rudolph V., Schopfer F.J., Khoo N.K., Rudolph T.K., Cole M.P., Woodcock S.R., Bonacci G., Groeger A.L., Golin-Bisello F., Chen C.S., et al. Nitro-fatty acid metabolome: saturation, desaturation, beta-oxidation, and protein adduction. J Biol Chem 2009, 284:1461-1473.
20. Ceaser E.K., Moellering D.R., Shiva S., Ramachandran A., Landar A., Venkartraman A., Crawford J., Patel R., Dickinson D.A., Ulasova E., et al. Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem Soc Trans 2004, 32:151-155.
21. Liebler D.C. Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol 2008, 21:117-128.
22. Rudolph T.K., Freeman B.A. Transduction of redox signaling by electrophile-protein reactions. Sci Signal 2009, 2:re7.
23. Bolgar M.S., Yang C.Y., Gaskell S.J. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J Biol Chem 1996, 271:27999-28001.
24. Loidl-Stahlhofen A., Spiteller G. Alpha-hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta 1994, 1211:156-160.
25. Holtzclaw W.D., Dinkova-Kostova A.T., Talalay P. Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul 2004, 44:335-367.
26. Kansanen E., Jyrkkanen H.-K., Volger O.L., Leinonen H., Kivela A.M., Hakkinen S.-K., Woodcock S.R., Schopfer F.J., Horrevoets A.J., Yla-Herttala S., et al. Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid. J Biol Chem 2009, 284:33233-33241.
27. Khoo N.K.H., Rudolph V., Cole M.P., Golin-Bisllo F., Schopfer F.J., Woodcock S.R., Batthyany C., Freeman B.A. Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1. Expression by electrophilc nitro-fatty acids. Free Radic Biol Med 2010, 48:230-239.
28. Wright M.M., Schopfer F.J., Baker P.R., Vidyasagar V., Powell P., Chumley P., Iles K.E., Freeman B.A., Agarwal A. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci U S A 2006, 103:4299-4304.
29. Villacorta L., Zhang J., Garcia-Barrio M.T., Chen X.L., Freeman B.A., Chen Y.E., Cui T. Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am J Physiol Heart Circ Physiol 2007, 293:H770-H776.
30. Lee C.H., Olson P., Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003, 144:2201-2207.
31. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y.E., Freeman B.A. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor γ ligand. Proc Natl Acad Sci U S A 2005, 102:2340-2345.
32. Itoh T., Fairall L., Amin K., Inaba Y., Szanto A., Balint B.L., Nagy L., Yamamoto K., Schwabe J.W.R. Structural basis for the activation of PPARγ by oxidized fatty acids. Nat Struct Mol Biol 2008, 15:924-931.
33. Alexander R.L., Wright M.W., Gorczynski M.J., Smitherman P.K., Akiyama T.E., Wood H.B., Berger J.P., King S.B., Morrow C.S. Differential potencies of naturally occurring regioisomers of nitrolinoleic acid in PPARγ activation. Biochemistry 2008, 48:492-498.
34. Li Y., Zhang J., Schopfer F.J., Martynowski D., Garcia-Barrio M.T., Kovach A., Suino-Powell K., Baker P.R., Freeman B.A., Chen Y.E., et al. Molecular recognition of nitrated fatty acids by PPARγ. Nat Struct Mol Biol 2008, 15:865-867.
35. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995, 83:803-812.
36. Yu K., Bayona W., Kallen C.B., Harding H.P., Ravera C.P., McMahon G., Brown M., Lazar M.A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995, 270:23975-23983.
37. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 1998, 93:229-240.
38. Vanhoutte P.M., Shimokawa H., Tang E.H.C., Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol 2009, 196:193-222.
39. Budhiraja R., Tuder R.M., Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 2004, 109:159-165.
40. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87:840-844.
41. Cho D.H., Choi Y.J., Jo S.A., Jo I. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) γ-dependent and PPARγ-independent signaling pathways. J Biol Chem 2004, 279:2499-2506.
42. Calnek D.S., Mazzella L., Roser S., Roman J., Hart C.M. Peroxisome proliferator-activated receptor γ ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 2003, 23:52-57.
43. Polikandriotis J.A., Mazzella L.J., Rupnow H.L., Hart C.M. Peroxisome proliferator-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ-dependent mechanisms. Arterioscler Thromb Vasc Biol 2005, 25:1810-1816.
44. Kleinhenz J.M., Kleinhenz D.J., You S., Ritzenthaler J.D., Hansen J.M., Archer D.R., Sutliff R.L., Hart C.M. Disruption of endothelial peroxisome proliferator-activated receptor-γ reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol 2009, 297:H1647-1654.
45. Ryan M.J., Didion S.P., Mathur S., Faraci F.M., Sigmund C.D. PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 2004, 43:661-666.
46. Matsuda Y., Hoshikawa Y., Ameshima S., Suzuki S., Okada Y., Tabata T., Sugawara T., Matsumura Y., Kondo T. Effects of peroxisome proliferator-activated receptor γ ligands on monocrotaline-induced pulmonary hypertension in rats. Nihon Kokyuki Gakkai Zasshi 2005, 43:283-288.
47. Nisbet RE, Bland JM, Kleinhenz DJ, Mitchell PO, Walp ER, Sutliff RL, Hart CM. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol. In press. doi:10.1165/rcmb.2008-0132OC.
48. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 2002, 14:879-897.
49. Cui T., Schopfer F.J., Zhang J., Chen K., Ichikawa T., Baker P.R., Batthyany C., Chacko B.K., Feng X., Patel R.P., et al. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J Biol Chem 2006, 281:35686-35698.
50. Cole M.P., Rudolph T.K., Khoo N.K.H., Motanya U.N., Golin-Bisllo F., Wertz J.W., Schopfer F.J., Woodcock S.R., Ali M.S., Rudolph V., et al. Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury. Circ Res 2009, 105:965-972.